{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:44:53Z","timestamp":1791290693182,"version":"4.3.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The risk of viral hepatitis among healthcare students (HCSs) is greater than that among the general population. Therefore, this study was conducted to investigate the seroprevalence of the hepatitis A virus (HAV), hepatitis B virus (HBV) and hepatitis C virus (HCV) among first-year HCSs at a university in Turkey and as a secondary objective, to determine the factors associated with HAV and HBV seropositivity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This cross-sectional study was performed in first-year HCSs in Izmir, western Turkey. Data were collected using a self-administered questionnaire including items on sociodemographic characteristics, medical history, and hygiene. A total of 650 HCSs were tested for the HAV, HBV and HCV markers. Categorical variables were compared using the chi-square test. The association between independent variables and anti-HAV seropositivity and anti-HBs seropositivity was assessed by multinomial logistic regression analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The overall frequency of total anti-HAV seropositivity was 34.9%. HBsAg, total anti-HBc and anti-HBs seropositivity were found in 0.3, 1.2 and 93.7% of samples, respectively. All of the HCSs were negative for anti-HCV. Total anti-HAV seropositivity was found to be 1.73 times higher in those \u226521\u2009years old, and it was 1.61 times higher in those who perceived their economic status to be average and 2.75 times higher in those who perceived their economic status to be low. Total anti-HAV seropositivity was found to be 4.37 times higher in those who lived in provinces with intermediate human development index levels. Total anti-HBs seropositivity was found to be 2.48 times higher in those \u226420\u2009years old, and it was 2.13 times higher in those who perceived their economic status to be average.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Approximately two out of three HCSs were susceptible to HAV infection. Since HCSs are at high risk for HAV infection, they should be vaccinated before medical clerkships begin. Our results indicate that there is a high prevalence of anti-HBs seropositivity among HCSs. This result may be largely attributed to the implementation of a successful vaccination program in Turkey since 1998.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-020-05247-5","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T10:04:10Z","timestamp":1595412250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Hepatitis A, B and C seropositivity among first-year healthcare students in western Turkey: a seroprevalence study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7749-705X","authenticated-orcid":false,"given":"Ayla","family":"Acikgoz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Cimrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Servet","family":"Kizildag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuran","family":"Esen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Balci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayca Arzu","family":"Sayiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,22]]},"reference":[{"key":"5247_CR1","volume-title":"Prevention & Control of Viral Hepatitis Infection: Framework for Global Action","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. Prevention & Control of Viral Hepatitis Infection: Framework for Global Action. Geneva: World Health Organization; 2012. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/130012\/WHO_HSE_PED_HIP_GHP_2012.1_eng.pdf?sequence=1 Accessed 11 Jun 2019."},{"key":"5247_CR2","unstructured":"Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine- preventable diseases. Hepatitis B; 2018. https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/hepb.html#hepb Accessed 15 June 2019."},{"key":"5247_CR3","unstructured":"World Health Organization. Global Hepatitis Report 2017. Geneva: World Health Organization (WHO); 2017. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/255016\/9789241565455-eng.pdf?sequence=1. Accessed 10 June 2019."},{"key":"5247_CR4","unstructured":"World Health Organization. Hepatitis A. https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/hepatitis-a Accessed 15 Jun 2019."},{"key":"5247_CR5","doi-asserted-by":"publisher","first-page":"6653","DOI":"10.1016\/j.vaccine.2010.08.037","volume":"28","author":"KH Jacobsen","year":"2010","unstructured":"Jacobsen KH, Wiersma ST. Hepatitis a virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28:6653\u20137.","journal-title":"Vaccine."},{"key":"5247_CR6","unstructured":"Turkish Ministry of Health. Viral hepatitis prevention and control program of Turkey (2018\u20132023). https:\/\/kms.kaysis.gov.tr\/(X (1) S(t2fx3bjfkw4034ljzk5borjk))\/Home\/Goster\/144104?AspxAutoDetectCookieSupport=1 Accessed 1 May 2020."},{"key":"5247_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/1471-2334-11-337","volume":"11","author":"M Toy","year":"2011","unstructured":"Toy M, Onder FO, Wormann T, Bozdayi AM, Schalm SW, Borsboom GJ, et al. Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review. BMC Infect Dis. 2011;11:337.","journal-title":"BMC Infect Dis"},{"key":"5247_CR8","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.cmi.2015.06.028","volume":"21","author":"N Tozun","year":"2015","unstructured":"Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z, Akarca U, et al. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clin Microbiol Infect. 2015;21:1020\u20136.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"5247_CR9","doi-asserted-by":"publisher","first-page":"e65395","DOI":"10.5812\/hepatmon.65395","volume":"18","author":"HG Kahraman","year":"2018","unstructured":"Kahraman HG, Ozbek OA, Emek M, Atasoylu G, Sekreter O, Unal B. Hepatitis B seroprevalence and the relationship between being hepatitis B vaccinated and infected with social determinants of health: Manisa, 2014. Hepat Mon. 2018;18(7):e65395.","journal-title":"Hepat Mon"},{"key":"5247_CR10","unstructured":"Peker E. Hepatitis A seroprevalence in healthcare students. Hatay, Turkey: Mustafa Kemal University Medical Faculty; 2015. [Unpublished Thesis]. https:\/\/tez.yok.gov.tr\/UlusalTezMerkezi\/TezGoster?key=Br_XTptK8CZ70f0JGX9xEizJiE00Pvq7zkY6GX_sNRyXU8MkH7scdG9LzpOsAsu-."},{"key":"5247_CR11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.5455\/pmb.1-1351757959","volume":"12","author":"A Ergin","year":"2013","unstructured":"Ergin A, Uzun SU, Bozkurt A\u0130, Til A, Sava\u015f E, Pakyurek H, et al. Hepatitis a seroprevalence and contributing factors in the sixth year medical faculty students. TAF Prev Med Bull. 2013;12:625\u201332.","journal-title":"TAF Prev Med Bull"},{"key":"5247_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4274\/Vhd.70288","volume":"19","author":"C Kader","year":"2013","unstructured":"Kader C, Yolcu S, Erbay A, Kilic Akca N, Yuzer S, Polat S. Investigation of hepatitis-B and C seroprevalences in Bozok University School of health students. Viral Hepat J. 2013;19:49\u201353.","journal-title":"Viral Hepat J"},{"key":"5247_CR13","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.ajic.2011.03.001","volume":"39","author":"S Kim","year":"2011","unstructured":"Kim S, Lee JH, Hwang JH, Lee CS. Hepatitis A antibody seroprevalence among medical school students. Am J Infect Control. 2011;39:889\u201390.","journal-title":"Am J Infect Control"},{"issue":"Suppl 1","key":"5247_CR14","first-page":"S9","volume":"19","author":"B Vakili","year":"2014","unstructured":"Vakili B, Rahimi H, Ataei B, Janghorbani M, Khorvash F, Shoaei P, et al. Hepatitis A seropositivity among newly admitted medical students of Isfahan, Kermanshah, and Hamedan: a seroprevalence study. J Res Med Sci. 2014;19(Suppl 1):S9\u2013S12.","journal-title":"J Res Med Sci"},{"key":"5247_CR15","doi-asserted-by":"publisher","first-page":"e26219","DOI":"10.5812\/hepatmon.26219","volume":"15","author":"SJ Hosseini Shokouh","year":"2015","unstructured":"Hosseini Shokouh SJ, Dadashi A, Abiri M, Zohrevand I, Eshraghian A, Khoshdel A, et al. HAV immunity in Iranian medical students. Hepat Mon. 2015;15:e26219.","journal-title":"Hepat Mon"},{"key":"5247_CR16","doi-asserted-by":"publisher","first-page":"e34219","DOI":"10.5812\/hepatmon.34219","volume":"16","author":"M Campagna","year":"2016","unstructured":"Campagna M, Mereu NM, Mulas L, Pilia R, Piazza MF, Spada L, et al. Pattern of hepatitis A virus epidemiology in nursing students and adherence to preventive measures at two training wards of a university hospital. Hepat Mon. 2016;16:e34219.","journal-title":"Hepat Mon"},{"key":"5247_CR17","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jiph.2016.09.020","volume":"10","author":"M Koroglu","year":"2017","unstructured":"Koroglu M, Jacobsen KH, Demiray T, Ozbek A, Erkorkmaz U, Altindis M. Socioeconomic indicators are strong predictors of hepatitis a seroprevalence rates in the Middle East and North Africa. J Infect Public Health. 2017;10:513\u20137.","journal-title":"J Infect Public Health"},{"key":"5247_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.healthpol.2004.12.004","volume":"74","author":"S Oncu","year":"2005","unstructured":"Oncu S, Oncu S, Sakarya S. Hepatitis A and B seropositivity among medical students. Health Policy. 2005;74:39\u201345.","journal-title":"Health Policy"},{"issue":"Suppl 3","key":"5247_CR19","first-page":"S208","volume":"5","author":"H Saneian","year":"2014","unstructured":"Saneian H, Rahimi H, Shoaei P. Hepatitis a seropositivity among first-year students of the Medical University in Isfahan, Iran. Int J Prev Med. 2014;5(Suppl 3):S208\u201312.","journal-title":"Int J Prev Med"},{"key":"5247_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1017\/S0950268815001302","volume":"144","author":"SG Hoseini","year":"2016","unstructured":"Hoseini SG, Kelishadi R, Ataei B, Yaran M, Motlagh ME, Ardalan G, et al. Seroprevalence of hepatitis a in Iranian adolescents: is it time to introduce a vaccine? Epidemiol Infect. 2016;144:291\u20136.","journal-title":"Epidemiol Infect"},{"key":"5247_CR21","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1186\/1471-2458-12-1047","volume":"12","author":"M Sheek-Hussein","year":"2012","unstructured":"Sheek-Hussein M, Hashmey R, Alsuwaidi AR, Al Maskari F, Amiri L, Souid AK, et al. Seroprevalence of measles, mumps, rubella, varicella-zoster and hepatitis A-C in Emirati medical students. BMC Public Health. 2012;12:1047.","journal-title":"BMC Public Health"},{"key":"5247_CR22","first-page":"445","volume":"66","author":"J Slusarczyk","year":"2012","unstructured":"Slusarczyk J, Ma\u0142kowski P, Bobilewicz D, Juszczyk G. Cross-sectional, anonymous screening for asymptomatic HCV infection, immunity to HBV, and occult HBV infection among health care workers in Warsaw, Poland. Przegl Epidemiol. 2012;66:445\u201351.","journal-title":"Przegl Epidemiol"},{"key":"5247_CR23","first-page":"1857","volume":"12","author":"ME C\u00e1rdenas-Perea","year":"2016","unstructured":"C\u00e1rdenas-Perea ME, G\u00f3mez-Conde E, Santos-L\u00f3pez G, et al. Hepatitis B surface antibodies in medical students from a public university in Puebla, Mexico. Hum Vaccin Immunother. 2016;12:1857\u201362.","journal-title":"Hum Vaccin Immunother"},{"key":"5247_CR24","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1086\/666335","volume":"33","author":"PR Spradling","year":"2012","unstructured":"Spradling PR, Williams RE, Xing J, Soyemi K, Towers J. Serologic testing for protection against hepatitis B virus infection among students at a health sciences university in the United States. Infect Control Hosp Epidemiol. 2012;33:732\u20136.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"5247_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12995-015-0083-4","volume":"10","author":"M Lamberti","year":"2015","unstructured":"Lamberti M, De Rosa A, Garzillo EM, Corvino AR, Sannolo N, De Pascalis S, et al. Vaccination against hepatitis b virus: are Italian medical students sufficiently protected after the public vaccination programme? J Occup Med Toxicol. 2015;10:41.","journal-title":"J Occup Med Toxicol"},{"key":"5247_CR26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1186\/1471-2458-14-577","volume":"14","author":"JM Alqahtani","year":"2014","unstructured":"Alqahtani JM, Abu-Eshy SA, Mahfouz AA, El-Mekki AA, Asaad AM. Seroprevalence of hepatitis B and C virus infections among health students and health care workers in the Najran region, southwestern Saudi Arabia: the need for national guidelines for health students. BMC Public Health. 2014;14:577.","journal-title":"BMC Public Health"},{"key":"5247_CR27","doi-asserted-by":"publisher","first-page":"8508","DOI":"10.1016\/j.vaccine.2007.10.018","volume":"25","author":"CC Lin","year":"2007","unstructured":"Lin CC, Chang CK, Huang YL, Tseng HF. Low seroprevalence of hepatitis B surface antibody among nursing students in Taiwan: an implication for boosting. Vaccine. 2007;25:8508\u201311.","journal-title":"Vaccine"},{"key":"5247_CR28","doi-asserted-by":"publisher","first-page":"712020","DOI":"10.1155\/2015\/712020","volume":"2015","author":"S Sernia","year":"2015","unstructured":"Sernia S, Ortis M, Antoniozzi T, Maffongelli E, La Torre G. Levels of anti-HBs antibody in HBV-vaccinated students enrolled in the faculty of medicine, dentistry and health professions of a large Italian University. Biomed Res Int. 2015;2015:712020.","journal-title":"Biomed Res Int"},{"key":"5247_CR29","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1080\/21645515.2017.1264788","volume":"13","author":"G Dini","year":"2016","unstructured":"Dini G, Toletone A, Barberis I, Debarbieri N, MassaE PC, et al. Persistence of protective anti-HBs antibody levels and anamnestic response to HBV booster vaccination: a cross-sectional study among healthcare students 20 years following the universal immunization campaign in Italy. Hum Vaccin Immunother. 2016;13:440\u20134.","journal-title":"Hum Vaccin Immunother"},{"key":"5247_CR30","doi-asserted-by":"publisher","first-page":"e29325","DOI":"10.5812\/hepatmon.29325","volume":"15","author":"K Dumaidi","year":"2015","unstructured":"Dumaidi K, Al-Jawabreh A. Persistence of anti-HBs among Palestinian medical students after 18-22 years of vaccination: a cross-sectional study. Hepat Mon. 2015;15:e29325.","journal-title":"Hepat Mon"},{"key":"5247_CR31","doi-asserted-by":"publisher","first-page":"e566","DOI":"10.4317\/medoral.20579","volume":"20","author":"MT Arias-Moliz","year":"2015","unstructured":"Arias-Moliz MT, Rojas L, Li\u00e9bana-Cabanillas F, Bernal C, Castillo F, Rodr\u00edguez-Archilla A, et al. Serologic control against hepatitis B virus among dental students of the University of Granada, Spain. Med Oral Patol Oral Cir Bucal. 2015;20:e566\u201371.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"5247_CR32","first-page":"13","volume":"15","author":"T Goktalay","year":"2010","unstructured":"Goktalay T, Cengiz OB. Seroprevalence of hepatitis B and the hepatitis B knowledge level of the university and vocational school students studying at health professional training at Celal Bayar University. Viral Hepat J. 2010;15:13\u201321.","journal-title":"Viral Hepat J"},{"key":"5247_CR33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1466-7657.2010.00804.x","volume":"57","author":"Z Irmak","year":"2010","unstructured":"Irmak Z, Ekinci B, Akgul AF. Hepatitis B and C seropositivity among nursing students at a Turkish university. Int Nurs Rev. 2010;57:365\u20139.","journal-title":"Int Nurs Rev"},{"key":"5247_CR34","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1590\/S0102-311X2011000400014","volume":"27","author":"NG Scaraveli","year":"2011","unstructured":"Scaraveli NG, Passos AM, Voigt AR, Livramento A, Tonial G, Treitinger A. Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil. Cadernos Sa\u00fade P\u00fablica. 2011;27:753\u20138.","journal-title":"Cadernos Sa\u00fade P\u00fablica"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05247-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05247-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05247-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T23:10:20Z","timestamp":1626909020000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05247-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,22]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5247"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05247-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,22]]},"assertion":[{"value":"24 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The institutional study approval was obtained from the Clinical Research Ethics Committee of Dokuz Eylul University, Izmir, Turkey. Participants were informed of their rights before signing the informed consent form, including the right to withdraw from the study at any time.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"529"}}